Health
Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus – News-Medical.Net
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndr…
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells. This drug could potentially be used to prevent virus infection. The research is published on the bioRxiv* preprint server in September 2020.
To combat the spread of COVID-19, researche…
-
Noosa News22 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News22 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
General19 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business11 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?